These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 29222745

  • 1. MiR-26a functions as a tumor suppressor in ambient particulate matter-bound metal-triggered lung cancer cell metastasis by targeting LIN28B-IL6-STAT3 axis.
    Lu YY, Lin Y, Ding DX, Su S, Chi QQ, Zhang YC, Sun J, Zhang X, Zhu HM, Huang QS, Chi YL, Ye GZ, Tao S, Dong SJ.
    Arch Toxicol; 2018 Mar; 92(3):1023-1035. PubMed ID: 29222745
    [Abstract] [Full Text] [Related]

  • 2. MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGβ8- JAK2/STAT3 axis.
    Song Q, Liu B, Li X, Zhang Q, Cao L, Xu M, Meng Z, Wu X, Xu K.
    Biochem Biophys Res Commun; 2018 Jun 22; 501(2):494-500. PubMed ID: 29746867
    [Abstract] [Full Text] [Related]

  • 3. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
    Liang H, Liu S, Chen Y, Bai X, Liu L, Dong Y, Hu M, Su X, Chen Y, Huangfu L, Li X, Gu Y, Shan H.
    J Mol Med (Berl); 2016 Jun 22; 94(6):655-65. PubMed ID: 26787543
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L, Sun S, Shi J, Cao F, Han X, Chen Z.
    Tumour Biol; 2017 Jun 22; 39(6):1010428317697579. PubMed ID: 28631574
    [Abstract] [Full Text] [Related]

  • 5. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J, Xu Y, Tao L, Pan Y, Zhang K, Wang R, Chen LB, Chu X.
    Cell Physiol Biochem; 2017 Jun 22; 41(2):583-597. PubMed ID: 28214878
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.
    Dang X, Ma A, Yang L, Hu H, Zhu B, Shang D, Chen T, Luo Y.
    Cancer Genet; 2012 Mar 22; 205(3):113-23. PubMed ID: 22469510
    [Abstract] [Full Text] [Related]

  • 7. MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells.
    Lin G, Liu B, Meng Z, Liu Y, Li X, Wu X, Zhou Q, Xu K.
    Exp Cell Res; 2017 Mar 15; 352(2):364-374. PubMed ID: 28237093
    [Abstract] [Full Text] [Related]

  • 8. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW, Chen PM, Hsieh YH, Weng CC, Chang CW, Yao CC, Hu LY, Wu PE, Shen CY.
    Oncotarget; 2015 Dec 29; 6(42):44222-38. PubMed ID: 26528854
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
    Yang Y, Ding L, Hu Q, Xia J, Sun J, Wang X, Xiong H, Gurbani D, Li L, Liu Y, Liu A.
    Mol Cancer; 2017 Aug 22; 16(1):141. PubMed ID: 28830450
    [Abstract] [Full Text] [Related]

  • 10. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
    Pan T, Zhang F, Li F, Gao X, Li Z, Li X, Ren X.
    Oncol Rep; 2020 Sep 22; 44(3):1049-1063. PubMed ID: 32705271
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
    Wang X, Chen Z.
    Int J Mol Med; 2015 Mar 22; 35(3):839-46. PubMed ID: 25604748
    [Abstract] [Full Text] [Related]

  • 12. MiR-563 restrains cell proliferation via targeting LIN28B in human lung cancer.
    Zhang X, Li M, Sun G, Bai Y, Lv D, Liu C.
    Thorac Cancer; 2020 Jan 22; 11(1):55-61. PubMed ID: 31766078
    [Abstract] [Full Text] [Related]

  • 13. miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis.
    Fu X, Meng Z, Liang W, Tian Y, Wang X, Han W, Lou G, Wang X, Lou F, Yen Y, Yu H, Jove R, Huang W.
    Oncogene; 2014 Aug 21; 33(34):4296-306. PubMed ID: 24056962
    [Abstract] [Full Text] [Related]

  • 14. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y, Li Y, Nian Y, Liu D, Dai F, Zhang J.
    BMC Cancer; 2015 Apr 19; 15():306. PubMed ID: 25928665
    [Abstract] [Full Text] [Related]

  • 15. MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.
    Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao W, Yan YF, Li BS, Wang PY, Xie SY.
    Cancer Biol Ther; 2017 Mar 04; 18(3):142-151. PubMed ID: 28106481
    [Abstract] [Full Text] [Related]

  • 16. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
    Bao X, Ren T, Huang Y, Wang S, Zhang F, Liu K, Zheng B, Guo W.
    J Exp Clin Cancer Res; 2016 Aug 30; 35(1):129. PubMed ID: 27576314
    [Abstract] [Full Text] [Related]

  • 17. miR-26a-5p restoration via EZH2 silencing blocks the IL-6/STAT3 axis to repress the growth of prostate cancer.
    Zhang W, Nie Q, Zhang X, Huang L, Pang G, Chu J, Yuan X.
    Expert Opin Ther Targets; 2023 Aug 30; 27(12):1285-1297. PubMed ID: 38155599
    [Abstract] [Full Text] [Related]

  • 18. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.
    Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, Xu K.
    Biochim Biophys Acta; 2012 Nov 30; 1822(11):1692-704. PubMed ID: 22885155
    [Abstract] [Full Text] [Related]

  • 19. miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
    Qin Q, Wei F, Zhang J, Li B.
    Oncol Rep; 2017 Feb 30; 37(2):823-830. PubMed ID: 28075475
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
    Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX.
    Hepatology; 2013 Jul 30; 58(1):158-70. PubMed ID: 23389848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.